MiMedx Group, Inc. provides revenue guidance for the financial year 2022. For the period, the company expects annual revenue growth of 11% to 14% in the Company's continuing portfolio of products.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.255 USD | +1.47% | -3.79% | -17.62% |
Apr. 30 | Transcript : MiMedx Group, Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
Apr. 30 | Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 Revenue $84.7M, vs. Street Est of $79.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.62% | 1.06B | |
-25.27% | 120M | |
-12.36% | 64.19M | |
-4.79% | 52.84M | |
-6.87% | 50.21M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- MiMedx Group, Inc. Provides Revenue Guidance for the Financial Year 2022